New Albany, OH, United States of America

David Beno

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Abbvie Inc.. Active years: 2016.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of David Beno in Pharmaceutical Chemistry

Introduction

David Beno is an accomplished inventor based in New Albany, OH (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on phenyl uracil compounds. His expertise and dedication have led to the development of valuable pharmaceutical products.

Latest Patents

David Beno holds a patent for "Formulations of phenyl uracil compounds." This patent describes a pharmaceutical product that comprises at least one phenyl uracil-based pharmaceutically active agent or an agent of related structural type, along with processes for obtaining such products. This innovation has the potential to impact the pharmaceutical industry positively.

Career Highlights

David Beno is currently employed at AbbVie Inc., a leading global biopharmaceutical company. His work at AbbVie has allowed him to focus on developing new therapeutic solutions that address unmet medical needs. With 1 patent to his name, Beno has established himself as a key figure in his field.

Collaborations

Throughout his career, David has collaborated with talented professionals, including Hao Hou and Ameesha Patel. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

David Beno's contributions to pharmaceutical chemistry exemplify the spirit of innovation in the industry. His work on phenyl uracil compounds showcases his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…